Literature DB >> 29094455

Incidence of gastric adenocarcinoma among lesions diagnosed as low-grade adenoma/dysplasia on endoscopic biopsy: A multicenter, prospective, observational study.

Akira Maekawa1, Motohiko Kato1, Takeshi Nakamura2, Masato Komori3, Takuya Yamada4, Katsumi Yamamoto5, Hideharu Ogiyama6, Masanori Nakahara7, Naoki Kawai8, Takamasa Yabuta9, Akira Mukai10, Yoshito Hayashi1, Tsutomu Nishida1,5, Hideki Iijima1, Masahiko Tsujii1, Eiichi Morii11, Tetsuo Takehara1.   

Abstract

BACKGROUND AND AIM: Differentiation between gastric adenocarcinoma and low-grade adenoma/dysplasia (LGA) on endoscopic forceps biopsy is difficult. We aim to clarify the incidence of carcinoma in specimens, obtained by endoscopic resection (ER), from cases that had been diagnosed as LGA (Vienna category 3) on endoscopic biopsy.
METHODS: In this multicenter, prospective, observational study, patients with gastric adenoma (Vienna category 3 or 4.1) diagnosed on endoscopic forceps biopsy were enrolled. All the specimens were subjected to histopathological central review. Primary endpoint was the incidence of carcinoma (Vienna category 4.2 or over) among the biopsy-proven gastric LGA. Secondary endpoints were the histological findings of resected specimens, clinicopathological features of carcinoma, and short-term outcomes of all ER cases.
RESULTS: Ninety-five patients with 104 lesions diagnosed as gastric adenoma were enrolled. After central review of the biopsy specimens, 47 lesions were diagnosed as LGA and seven lesions (15%) as adenocarcinoma (95% confidence interval, 7.6-28%). Carcinoma was detected in lesions that had a minimum size of 6 mm; the incidence of carcinoma was higher in the larger lesions. There was a histological discrepancy between biopsy and ER material in more than 60% of the cases.
CONCLUSIONS: A substantial proportion of biopsy-proven gastric LGA specimens were diagnosed as adenocarcinoma after ER. This indicated histological discrepancy between biopsy-proven gastric LGA and histology of the resected material.
© 2017 Japan Gastroenterological Endoscopy Society.

Entities:  

Keywords:  early diagnosis of cancer; endoscopic submucosal dissection; gastric cancer; gastric neoplasm; prospective study

Mesh:

Year:  2017        PMID: 29094455     DOI: 10.1111/den.12980

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  5 in total

1.  Multiple metabolic parameters and visual assessment of 18F-FDG uptake heterogeneity of PET/CT in advanced gastric cancer and primary gastric lymphoma.

Authors:  Yixuan Ren; Juan Liu; Ling Wang; Yongjun Luo; Xiaofang Ding; Aiqi Shi; Jiangyan Liu
Journal:  Abdom Radiol (NY)       Date:  2020-11

2.  Discrepancy Between Forceps Biopsy and Resection in Colorectal Polyps: A 1686 Paired Screening-Therapeutic Colonoscopic Finding.

Authors:  Yuanxi Jiang; Junwen Wang; Ying Chen; Huihui Sun; Zhiyu Dong; Shuchang Xu
Journal:  Ther Clin Risk Manag       Date:  2022-05-16       Impact factor: 2.755

3.  Feedback from artificial intelligence improved the learning of junior endoscopists on histology prediction of gastric lesions.

Authors:  Thomas K L Lui; Kenneth K Y Wong; Loey L Y Mak; Elvis W P To; Vivien W M Tsui; Zijie Deng; Jiaqi Guo; Li Ni; Michael K S Cheung; Wai K Leung
Journal:  Endosc Int Open       Date:  2020-01-22

4.  Risk factors for the histologic discrepancy of gastric adenomatous lesions and long-term outcome.

Authors:  Jong Seok Joo; Jae Ho Park; Ju Seok Kim; Sun Hyung Kang; Hee Seok Moon; Jae Kyu Sung; Hyun Yong Jeong
Journal:  Medicine (Baltimore)       Date:  2021-11-12       Impact factor: 1.817

5.  Clinical Outcomes of Endoscopic Resection for Low-Grade Dysplasia and High-Grade Dysplasia on Gastric Pretreatment Biopsy: Korea ESD Study Group.

Authors:  Jung Won Jeon; Soo Jin Kim; Jae Young Jang; Sun-Moon Kim; Chul-Hyun Lim; Jae Myung Park; Su Jin Hong; Chan Gyoo Kim; Seong Woo Jeon; Si Hyung Lee; Jae Kyu Sung; Gwang Ho Baik
Journal:  Gut Liver       Date:  2021-03-15       Impact factor: 4.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.